The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide.
Saved in:
| Title: | The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide. |
|---|---|
| Authors: | Roger S; Département Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux, Suresnes, France., Badier-Commander C, Paysant J, Cordi A, Verbeuren TJ, Félétou M |
| Source: | British journal of pharmacology [Br J Pharmacol] 2010 Nov; Vol. 161 (5), pp. 1044-58. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20977455 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Roger+S%22">Roger S</searchLink>; Département Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Badier-Commander+C%22">Badier-Commander C</searchLink><br /><searchLink fieldCode="AU" term="%22Paysant+J%22">Paysant J</searchLink><br /><searchLink fieldCode="AU" term="%22Cordi+A%22">Cordi A</searchLink><br /><searchLink fieldCode="AU" term="%22Verbeuren+TJ%22">Verbeuren TJ</searchLink><br /><searchLink fieldCode="AU" term="%22Félétou+M%22">Félétou M</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227502536%22">British journal of pharmacology</searchLink> [Br J Pharmacol] 2010 Nov; Vol. 161 (5), pp. 1044-58. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502536 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5381 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071188%22">00071188 </searchLink><i>NLM ISO Abbreviation: </i>Br J Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20977455 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/j.1476-5381.2010.00943.x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1044 Titles: – TitleFull: The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Roger S – PersonEntity: Name: NameFull: Badier-Commander C – PersonEntity: Name: NameFull: Paysant J – PersonEntity: Name: NameFull: Cordi A – PersonEntity: Name: NameFull: Verbeuren TJ – PersonEntity: Name: NameFull: Félétou M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2010 Nov Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1476-5381 Numbering: – Type: volume Value: 161 – Type: issue Value: 5 Titles: – TitleFull: British journal of pharmacology Type: main |
| ResultId | 1 |
